ABOUT PEMBROLIZUMAB J CODE 2015

This stops the activation with the T-cell which Generally would target and wipe out cancer. The cancer cells can then multiply and spread. When Keytruda binds for the PD-one receptor it prevents cancer cells from linking to and inactivating T-cells, permitting T-cell re-activation, and boosting the immune system's response against cancer. This affe